Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.443.842.822.952.81

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 4.44 based on Mar2025 Standalone results.
Year Working Capital/Sales
Mar20254.44
Mar20243.84
Mar20232.82
Mar20222.95
Mar20212.81

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 4.44
15.63
Mar2024 3.84
36.17
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹491.9 Cr -4% 23.4% 173.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4%

23.4%

173.2%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses